Corbus Pharmaceuticals Holdings Inc.

(CRBP) Trade

By |

Profile

Corbus Pharmaceuticals Holdings Inc is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

Contact Information

Website: www.corbuspharma.com
Email: ir@corbuspharma.com
Main Phone: +1 617 963-0100
Address: 500 River Ridge Drive
Address 2: Second Floor
State: MA
City / Town: Norwood
Country: USA
Postal Code: 02062

Issuer Information

Exchange: NSD
CEO: Yuval Cohen
Employees: 47
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 6.90 $ 0.24 (3.60%)
Last Price 6.90 Change $ 0.24 Change % 3.60 Tick N/A
Bid 6.80 Bid Size 1,500.00 Ask 7.10 Ask Size 300.00
Open 6.99 High 7.22 Low 6.78 Prev Close 6.66
Last Trade Volume 733,053 52 Wk Hi 9.96 52 Wk Low 4.50
Market Cap 394.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 57,237,496.00 EPS (TTM) -0.89 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 32 32 32 32
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 24.67 24.67 24.67 24.67
Standard Deviation 6.43 6.43 6.43 6.43
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 5 5 5
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.2 1.17 1.17 1.17